Results 31 to 40 of about 77,563 (210)

Mycobacterium bolletii Respiratory Infections

open access: yesEmerging Infectious Diseases, 2009
Contrary to other species in the Mycobacterium chelonae-abscessus complex, we reidentified M. bolletii strains isolated from 4 respiratory patients and found these strains to be uniformly resistant to clarithromycin.
Toïdi Adékambi, Michel Drancourt
doaj   +1 more source

Mycobacterium ulcerans infection: control, diagnosis, and treatment. [PDF]

open access: yes, 2006
The skin disease Buruli ulcer, caused by Mycobacterium ulcerans, is the third most common mycobacterial disease after tuberculosis and leprosy and mainly affects remote rural African communities. Although the disease is known to be linked to contaminated
Adjei   +64 more
core   +2 more sources

Mycobacterium riyadhense as the opportunistic infection that lead to HIV diagnosis: A report of 2 cases and literature review

open access: yesJournal of Infection and Public Health, 2019
Human immunodeficiency virus (HIV) infection usually presents with a wide range of manifestations. Although HIV patients are prone to pulmonary infections by opportunistic pathogens in the late stage of AIDS, manifesting the disease with pulmonary ...
Thamer H. Alenazi   +5 more
doaj   +1 more source

Mycobacterium szulgai cavitary lung disease progression over a three year period – A case report

open access: yesIDCases, 2022
Mycobacterium szulgai is a slow growing non-tuberculous mycobacterium associated with rare but severe infections. It most commonly presents as pulmonary disease in people with underlying structural lung disease.
Michael C. Croix, Sonal S. Munsiff
doaj   +1 more source

Molecular identification and typing of Mycobacterium massiliense isolated from postsurgical infections in Brazil

open access: yesBrazilian Journal of Infectious Diseases
OBJECTIVE: One hundred thirty-one cases of postsurgical infections were reported in Southern Region of Brazil between August 2007 and January 2008.
Fernanda Monego   +9 more
doaj   +1 more source

A Rare Case of Intestinal Tuberculosis Mimicking Colon Cancer in a Chronic Kidney Disease Patient

open access: yesJournal of Clinical and Diagnostic Research
Intestinal Tuberculosis (ITB) is an uncommon form of extrapulmonary TB that poses a diagnostic challenge due to its nonspecific symptoms and radiological resemblance to malignancy.
Anuja Makan   +4 more
doaj   +1 more source

Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin [PDF]

open access: yes, 2013
Buruli ulcer (BU), caused by Mycobacterium ulcerans is a chronic necrotizing skin disease. It usually starts with a subcutaneous nodule or plaque containing large clusters of extracellular acid-fast bacilli.
AA Pahlevan   +45 more
core   +3 more sources

Alcohol‐induced altered glycans in human tracheal epithelial cells promote bacterial adhesion

open access: yesFEBS Open Bio, EarlyView.
Alcohol induces altered glycans to promote bacteria adhesion. Heavy alcohol drinking is known to increase the risk of bacterial pneumonia. However, the link between alcohol levels and risk of infection remains underexplored. Recently, we found that alcohol induced α2‐6sialo mucin O‐glycans in human tracheobronchial epithelial cells, which mediated the ...
Pi‐Wan Cheng   +2 more
wiley   +1 more source

Tongue Tuberculosis as a Complication of Pott’s Disease in a Patient on Systemic Steroid Therapy without Pulmonary Tuberculosis

open access: yesMedicina
A 78-year-old man with a previous diagnosis of rheumatoid arthritis on prolonged treatment with corticosteroids presented with intense and progressive pain at the cervical level that prevented him from resting his head and walking, in addition to an ...
Samuel Sevilla-Fuentes   +5 more
doaj   +1 more source

Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera

open access: yesInternational Journal of Infectious Diseases, 2019
Ruxolitinib is a JAK-1/JAK-2 inhibitor indicated for the treatment of polycythemia vera and primary or secondary myelofibrosis. Only one patient (0.2%) was diagnosed with tuberculosis among the 485 patients receiving ruxolitinib in the four pivotal ...
Sylvain Lescuyer   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy